Recruiting

Observational Study

Sponsor:

CureScience

Code:

NCT05106725

Conditions

Brain Cancer

Neurological Disorder

Neurological Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.

Conditions

Brain Cancer

Neurological Disorder

Neurological Cancer

Study ID

NCT05106725

Start date

Oct 11, 2021

Status verified date

Aug, 2024

Completion date

Dec 31, 2025

Anticipated

Primary completion date

Dec 31, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form.
  • Participant is ≥ 18 years of age.
  • Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility.
  • Participant is characterized by at least one of the following criteria:

1. Has a neurological complication from any type of cancer, or is under evaluation for a possible cancer diagnosis or neurologic complication. Participant may be newly diagnosed, in relapse, or be free of disease at the time of recruitment. Participant without a confirmed cancer diagnosis is eligible.; OR
2. Has a neurological disorder, or is under evaluation for a possible diagnosis of a neurological disorder; OR
3. Does not meet the characteristic of either a. or b. above. This participant would be considered a "healthy control" for cancer and neurological disorders.

Exclusion Criteria:

  • Participant or participant's legally authorized representative is unable to provide informed consent.

Study Design

Enrollment

3500 participants

Anticipated

Interventions and Outcome Measures

Arms

Neurological patients

This cohort will include patients having been diagnosed with a neurological condition.

Control

This cohort will include patients who have not been diagnosed with a neurological disorder.

Primary outcome measure

  • Specimen and data storage [ Time Frame: 4 years ]

Central Contacts and Locations

Central contacts

Amanda Wilburn

8588002873awilburn@curescience.orgg

Locations

CureScience Institute

Recruiting

San Diego, California, United States, 92121

Principal Investigator:

Feng Lin, MD PhD

More Information

Sponsor

CureScience

Last update posted

Aug 21, 2024

Last verified

Aug, 2024

Keywords

  • wearables
  • digital health
  • biospecimens

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by CureScience on 2024-08-21.